WCRC

The Wales Cancer Research Centre is funded by the Welsh Government and is a vital part of Health and Care Research Wales’ infrastructure. It is led from Cardiff University, but with an all-Wales brief.  

Find out more about WCRW project HERE

UK-Qatar Healthcare Collaboration

The UK-Qatar precision healthcare is a collaboration between FCDA, Swansea University, UCL, QMUL, Barts, Qatar foundation, Hamad and Sidra Medicine. Prof Steve Conlan, Swansea University, leads the precision cancer care branch with researchers and clinicians in Doha using cutting edge functional genomic techniques. This project is active until 2025.

MRC IAA

The MRC IAA supports translational research in therapeutics and diagnostics. This funding aims to bridge the gap to significant future translational funding. Previously known as the MRC CiC, RBGO have been able to secure IAA funding for advancement of drug delivery systems that the group are developing.

Continuum

ReNeuron, IgInnovations and Swansea University  will undertake research to understand what type of cancers exosomes can be used to treat, and how they can be prepared ready for clinical trials.  

Find out more about the RISE project HERE

CALIN

The Celtic Advanced Life Science Innovation Network (CALIN) offers enterprises research and development opportunities. The network provides open access to experts, facilities and research and development. Click HERE to visit the CALIN website 

ACNM

The Avenues of Commercialisation for Nano and Micro-technologies (ACNM) Project is a business support scheme  that offers expertise and facilities to companies developing new or existing technologies, products and processes.